Production (Stage)
Tonix Pharmaceuticals Holding Corp.
TNXP
$28.93
$2.539.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -131.93M | -130.04M | -135.25M | -149.01M | -98.59M |
| Total Depreciation and Amortization | 2.94M | 3.46M | 3.99M | 4.45M | 4.41M |
| Total Amortization of Deferred Charges | 365.00K | 802.00K | 840.00K | 869.00K | 502.00K |
| Total Other Non-Cash Items | 67.36M | 59.08M | 62.07M | 62.63M | 2.29M |
| Change in Net Operating Assets | 1.33M | 5.78M | -278.00K | 7.84M | 4.72M |
| Cash from Operations | -59.93M | -60.93M | -68.64M | -73.22M | -86.67M |
| Capital Expenditure | -18.00K | -120.00K | -555.00K | -2.36M | -4.20M |
| Sale of Property, Plant, and Equipment | -- | -- | 7.00K | 999.00K | 999.00K |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -22.17M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.00K | -120.00K | -548.00K | -1.36M | -25.38M |
| Total Debt Issued | -- | -- | 8.94M | 8.94M | 8.94M |
| Total Debt Repaid | -11.77M | -2.35M | -1.65M | -940.00K | -235.00K |
| Issuance of Common Stock | 211.94M | 147.46M | 69.44M | 30.59M | 19.23M |
| Repurchase of Common Stock | -3.05M | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.51M | -10.24M | 13.69M | 15.21M | 19.87M |
| Cash from Financing | 184.62M | 134.87M | 90.43M | 53.80M | 47.81M |
| Foreign Exchange rate Adjustments | -1.00K | 4.00K | -30.00K | -25.00K | -26.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.67M | 73.83M | 21.22M | -20.80M | -64.27M |